• Publications
  • Influence
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery
In these structure activity studies, the 46 analogs of the 27-amino-acid form of the pituitary-adenylate-cyclase-activating peptide, PACAP(1-27), and the 38-amino-acid form, PACAP(1-38), were eitherExpand
  • 212
  • 14
Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
To compare the proportions of four muscarinic receptors in different rat brain regions, we used competition curves with four selective antagonists, at 1-[N-methyl-3H]scopolamine methyl chloride [(Expand
  • 237
  • 8
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J
We characterized highly selective receptors for PACAP, the pituitary adenylate cyclase activating peptide, in the tumoral acinar cell line AR 4‐2J derived from the rat pancreas. PACAP, a novelExpand
  • 118
  • 6
Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord
A high density (in the pmol/mg protein range) of specific functional receptors for PACAP (pituitary adenylate cyclase activating polypeptide) was observed in membranes from rat brain cortex,Expand
  • 95
  • 6
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1–27) and PACAP (1–38)) interact with distinct receptors on rat pancreatic AR 4‐2J cell membranes
The existence of specific receptors for the two PACAPs (Pituirary Adenylate Cyclase Activating Peptides of 27 and 38 amino acids) was previously demonstrated on membranes from the pancreatic acinarExpand
  • 69
  • 4
Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP
Adenylate cyclase stimulation by GH-releasing factor (GRF) and 14 GRF analogs (modified in the N-terminal part) was compared to the capacity of the same peptides to inhibit [125I]iodo-vasoactiveExpand
  • 153
  • 3
The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK
We investigated the ability of two forms of Pituitary Adenylate Cyclase Activating Polypeptide [PACAP-38, the 38 amino acid peptide isolated from ovine hypothalamus, and PACAP-27, a shorterExpand
  • 112
  • 3
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
N-terminally shortened analogs of the 27-amino-acid and 38-amino-acid forms of the pituitary-adenylate-cyclase-activating neuropeptide, PACAP(1-27) and PACAP(1-38), were synthesized by a solid-phaseExpand
  • 55
  • 3
A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblasts
A new type of VIP receptor was characterized in human SUP‐T1 lymphoblasts. The order of potency of unlabeled peptides in the presence of [125I]helodermin, was: helodermin(1–35)‐NH2 =Expand
  • 62
  • 2
Rat pancreatic hydrolases from birth to weaning and dietary adaptation after weaning.
KoRBERECHT, P., M. DESCHODT-LANCKMAN, J. CAMUS, J. BRUYLANDS, AND J. CHRISTOPHE. Rat pancreatic hydrolases from birth to weaning and dietary adaptation cfter weaning. Am. J. Physi~l. 221(l): 376-381.Expand
  • 96
  • 2
...
1
2
3
4
5
...